INB-200 shows significantly improved progression-free survival in glioblastoma patients, with favorable safety profile and no serious toxicities reported. Repeated doses of INB-200 demonstrated an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback